Nancy Elsa Mueller, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HTLV-I Infections | 38 | 2009 | 103 | 2.930 |
Why?
|
| Hodgkin Disease | 16 | 2017 | 1383 | 1.760 |
Why?
|
| Carrier State | 24 | 2006 | 529 | 1.300 |
Why?
|
| Human T-lymphotropic virus 1 | 19 | 2009 | 143 | 1.210 |
Why?
|
| Herpesvirus 4, Human | 16 | 2017 | 1078 | 1.010 |
Why?
|
| Antibodies, Viral | 17 | 2021 | 3210 | 0.840 |
Why?
|
| HTLV-I Antibodies | 21 | 2005 | 35 | 0.830 |
Why?
|
| Epstein-Barr Virus Infections | 5 | 2017 | 617 | 0.740 |
Why?
|
| Hepatitis C | 13 | 2004 | 1596 | 0.600 |
Why?
|
| Hepacivirus | 11 | 2006 | 1343 | 0.530 |
Why?
|
| Japan | 27 | 2009 | 1415 | 0.530 |
Why?
|
| Gene Products, tax | 7 | 2004 | 51 | 0.520 |
Why?
|
| Infectious Mononucleosis | 4 | 2013 | 133 | 0.410 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2011 | 276 | 0.390 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 3 | 2011 | 158 | 0.380 |
Why?
|
| Vitamin B Complex | 1 | 2011 | 299 | 0.320 |
Why?
|
| Leukemia, T-Cell | 4 | 2001 | 102 | 0.310 |
Why?
|
| Methionine | 1 | 2011 | 569 | 0.310 |
Why?
|
| Sexually Transmitted Diseases, Viral | 2 | 2000 | 39 | 0.310 |
Why?
|
| Tuberculin | 3 | 1999 | 63 | 0.300 |
Why?
|
| NF-kappa B | 2 | 2009 | 2487 | 0.300 |
Why?
|
| Lymphoma, Non-Hodgkin | 5 | 1994 | 1376 | 0.280 |
Why?
|
| Hepatitis C Antibodies | 5 | 2004 | 151 | 0.260 |
Why?
|
| Sarcoma, Kaposi | 4 | 2005 | 376 | 0.260 |
Why?
|
| Case-Control Studies | 20 | 2017 | 22230 | 0.260 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 6 | 2005 | 166 | 0.260 |
Why?
|
| Genitalia, Male | 1 | 2006 | 87 | 0.250 |
Why?
|
| Papillomaviridae | 4 | 2006 | 1137 | 0.250 |
Why?
|
| Viral Proteins | 2 | 2011 | 1798 | 0.250 |
Why?
|
| Connecticut | 4 | 2015 | 365 | 0.250 |
Why?
|
| Proviruses | 9 | 2005 | 319 | 0.230 |
Why?
|
| Circumcision, Male | 1 | 2006 | 148 | 0.230 |
Why?
|
| Folic Acid | 1 | 2011 | 1338 | 0.230 |
Why?
|
| Retinal Neoplasms | 1 | 2005 | 146 | 0.210 |
Why?
|
| Seroepidemiologic Studies | 5 | 2004 | 404 | 0.200 |
Why?
|
| Retinoblastoma | 1 | 2005 | 316 | 0.200 |
Why?
|
| Viral Core Proteins | 2 | 2002 | 158 | 0.200 |
Why?
|
| Anticarcinogenic Agents | 1 | 2004 | 250 | 0.200 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2004 | 361 | 0.190 |
Why?
|
| Lymphoma, AIDS-Related | 2 | 1999 | 79 | 0.190 |
Why?
|
| Fruit | 2 | 2015 | 1167 | 0.190 |
Why?
|
| Vegetables | 2 | 2015 | 1200 | 0.190 |
Why?
|
| RNA, Viral | 6 | 2002 | 2864 | 0.180 |
Why?
|
| Social Environment | 2 | 2004 | 1011 | 0.180 |
Why?
|
| Genome, Viral | 1 | 2004 | 671 | 0.170 |
Why?
|
| Child Welfare | 1 | 2004 | 521 | 0.170 |
Why?
|
| Odds Ratio | 10 | 2015 | 9654 | 0.160 |
Why?
|
| Tuberculin Test | 4 | 2004 | 205 | 0.160 |
Why?
|
| Antigens, Viral | 6 | 2013 | 994 | 0.150 |
Why?
|
| Blood Donors | 4 | 2004 | 342 | 0.150 |
Why?
|
| Adult | 54 | 2021 | 223109 | 0.140 |
Why?
|
| Lymphoma, B-Cell | 1 | 2004 | 943 | 0.140 |
Why?
|
| Gene Products, rex | 1 | 1997 | 6 | 0.140 |
Why?
|
| Lymphocytes | 6 | 1999 | 2601 | 0.140 |
Why?
|
| Middle Aged | 56 | 2021 | 223058 | 0.140 |
Why?
|
| Male | 68 | 2021 | 363808 | 0.140 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2004 | 663 | 0.140 |
Why?
|
| Virus Diseases | 1 | 2003 | 718 | 0.140 |
Why?
|
| Deltaretrovirus Infections | 1 | 1996 | 25 | 0.130 |
Why?
|
| Socioeconomic Factors | 5 | 2015 | 7838 | 0.130 |
Why?
|
| Agglutination Tests | 3 | 2001 | 43 | 0.130 |
Why?
|
| G(M1) Ganglioside | 2 | 1996 | 87 | 0.130 |
Why?
|
| Female | 66 | 2021 | 396159 | 0.130 |
Why?
|
| Aged | 45 | 2021 | 171233 | 0.120 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1997 | 561 | 0.120 |
Why?
|
| Rectal Diseases | 1 | 1996 | 141 | 0.120 |
Why?
|
| Liver Neoplasms | 5 | 2006 | 4350 | 0.120 |
Why?
|
| Humans | 96 | 2021 | 766011 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 2003 | 1387 | 0.120 |
Why?
|
| Diet | 4 | 2015 | 8085 | 0.110 |
Why?
|
| Disease Transmission, Infectious | 2 | 1996 | 560 | 0.110 |
Why?
|
| Mexico | 5 | 2006 | 771 | 0.110 |
Why?
|
| Adolescent | 24 | 2021 | 88804 | 0.110 |
Why?
|
| Leukocyte Count | 3 | 1997 | 1603 | 0.110 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 2 | 2011 | 28 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2011 | 16040 | 0.100 |
Why?
|
| Risk Factors | 23 | 2017 | 74870 | 0.100 |
Why?
|
| Sexual Behavior | 5 | 2005 | 2192 | 0.100 |
Why?
|
| Family Health | 1 | 1998 | 1253 | 0.100 |
Why?
|
| Immunoglobulin A | 2 | 2013 | 992 | 0.100 |
Why?
|
| Aspirin | 1 | 2004 | 3135 | 0.100 |
Why?
|
| Blood Banks | 1 | 1992 | 108 | 0.100 |
Why?
|
| Hypersensitivity, Delayed | 2 | 1990 | 490 | 0.090 |
Why?
|
| Thymidylate Synthase | 1 | 2011 | 73 | 0.090 |
Why?
|
| Interleukin-10 | 1 | 2017 | 1183 | 0.090 |
Why?
|
| Marriage | 3 | 2000 | 351 | 0.090 |
Why?
|
| Viremia | 2 | 2004 | 727 | 0.090 |
Why?
|
| Prevalence | 9 | 2005 | 15833 | 0.090 |
Why?
|
| Cell Transformation, Viral | 1 | 1992 | 527 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1997 | 1856 | 0.090 |
Why?
|
| Smoking | 8 | 2005 | 9082 | 0.090 |
Why?
|
| Phytohemagglutinins | 1 | 1990 | 164 | 0.090 |
Why?
|
| Immunoglobulin M | 3 | 1991 | 1527 | 0.080 |
Why?
|
| Logistic Models | 6 | 2011 | 13271 | 0.080 |
Why?
|
| Military Personnel | 3 | 2017 | 1260 | 0.080 |
Why?
|
| Lymphoma, T-Cell | 1 | 1992 | 308 | 0.080 |
Why?
|
| Capsid Proteins | 2 | 1991 | 467 | 0.080 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1996 | 1127 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 1999 | 2643 | 0.080 |
Why?
|
| Jamaica | 2 | 2009 | 54 | 0.080 |
Why?
|
| Alcohol Drinking | 6 | 2005 | 4041 | 0.080 |
Why?
|
| T-Lymphocytes | 6 | 2009 | 10262 | 0.080 |
Why?
|
| Paraparesis, Tropical Spastic | 3 | 2000 | 32 | 0.080 |
Why?
|
| Confidence Intervals | 3 | 2004 | 2914 | 0.070 |
Why?
|
| Carbon | 1 | 2011 | 676 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1992 | 2470 | 0.070 |
Why?
|
| Registries | 2 | 2004 | 8321 | 0.070 |
Why?
|
| Aged, 80 and over | 20 | 2021 | 59526 | 0.070 |
Why?
|
| Hepatitis C Antigens | 2 | 2004 | 35 | 0.070 |
Why?
|
| DNA Primers | 1 | 2011 | 2823 | 0.070 |
Why?
|
| Interleukin-6 | 1 | 2017 | 3229 | 0.070 |
Why?
|
| Genotype | 3 | 2011 | 13024 | 0.070 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 2004 | 2204 | 0.070 |
Why?
|
| Massachusetts | 4 | 2015 | 8878 | 0.070 |
Why?
|
| Food | 1 | 2011 | 764 | 0.070 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1994 | 1811 | 0.060 |
Why?
|
| Skin | 1 | 1999 | 4479 | 0.060 |
Why?
|
| DNA, Viral | 5 | 2005 | 2200 | 0.060 |
Why?
|
| Young Adult | 6 | 2021 | 59870 | 0.060 |
Why?
|
| Epidemiology | 1 | 2008 | 278 | 0.060 |
Why?
|
| Boston | 2 | 2011 | 9341 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 6 | 2005 | 6062 | 0.060 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2005 | 113 | 0.060 |
Why?
|
| Neoplasms | 3 | 2003 | 22350 | 0.060 |
Why?
|
| Cohort Studies | 14 | 2004 | 41652 | 0.060 |
Why?
|
| Sex Distribution | 3 | 2004 | 2268 | 0.060 |
Why?
|
| Matched-Pair Analysis | 1 | 2004 | 284 | 0.060 |
Why?
|
| Antibodies | 1 | 1992 | 2416 | 0.060 |
Why?
|
| Communicable Diseases | 1 | 1992 | 874 | 0.050 |
Why?
|
| Viral Load | 4 | 2004 | 3385 | 0.050 |
Why?
|
| Pregnancy | 2 | 2005 | 30253 | 0.050 |
Why?
|
| Papillomavirus Infections | 2 | 2006 | 1637 | 0.050 |
Why?
|
| Cytomegalovirus | 1 | 1988 | 751 | 0.050 |
Why?
|
| Skin Tests | 2 | 1999 | 630 | 0.050 |
Why?
|
| Tonsillectomy | 1 | 1987 | 284 | 0.050 |
Why?
|
| Age Distribution | 3 | 2004 | 2865 | 0.050 |
Why?
|
| Risk | 6 | 2004 | 9600 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2006 | 2326 | 0.050 |
Why?
|
| Immunoglobulin G | 3 | 1991 | 4526 | 0.050 |
Why?
|
| Vitamins | 1 | 2011 | 1632 | 0.050 |
Why?
|
| Mycobacterium tuberculosis | 1 | 1994 | 1914 | 0.050 |
Why?
|
| Haplotypes | 1 | 2009 | 2728 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 1999 | 4904 | 0.050 |
Why?
|
| Herpesvirus 8, Human | 2 | 2005 | 254 | 0.050 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 2002 | 74 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 1997 | 12768 | 0.050 |
Why?
|
| Selection Bias | 1 | 2004 | 359 | 0.050 |
Why?
|
| Testicular Neoplasms | 1 | 1988 | 802 | 0.050 |
Why?
|
| Incidence | 6 | 2004 | 21507 | 0.050 |
Why?
|
| Age Factors | 8 | 1999 | 18384 | 0.050 |
Why?
|
| HIV Infections | 3 | 2004 | 17531 | 0.050 |
Why?
|
| Gene Products, env | 1 | 2002 | 251 | 0.050 |
Why?
|
| Sex Factors | 5 | 2001 | 10605 | 0.050 |
Why?
|
| Chile | 1 | 2021 | 258 | 0.040 |
Why?
|
| Multivariate Analysis | 5 | 2004 | 12060 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 1999 | 5838 | 0.040 |
Why?
|
| Epidemiologic Methods | 2 | 1999 | 1325 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 1988 | 2324 | 0.040 |
Why?
|
| Occupations | 2 | 1992 | 516 | 0.040 |
Why?
|
| Spouses | 1 | 2002 | 286 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2005 | 1505 | 0.040 |
Why?
|
| Rural Population | 4 | 2004 | 2317 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2009 | 5501 | 0.040 |
Why?
|
| Hepatitis C, Chronic | 1 | 2006 | 1032 | 0.040 |
Why?
|
| Peru | 1 | 2021 | 887 | 0.040 |
Why?
|
| Immunity, Cellular | 1 | 2004 | 1553 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2001 | 1643 | 0.040 |
Why?
|
| Cross-Sectional Studies | 6 | 2005 | 26283 | 0.040 |
Why?
|
| Hepatitis B | 2 | 1995 | 708 | 0.040 |
Why?
|
| Sexually Transmitted Diseases | 2 | 1996 | 667 | 0.040 |
Why?
|
| Viral Matrix Proteins | 1 | 1998 | 192 | 0.040 |
Why?
|
| Polymorphism, Genetic | 2 | 2005 | 4249 | 0.040 |
Why?
|
| United States Department of Defense | 1 | 2017 | 36 | 0.040 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1998 | 341 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2005 | 1620 | 0.030 |
Why?
|
| Serologic Tests | 2 | 2004 | 382 | 0.030 |
Why?
|
| Anus Diseases | 1 | 1996 | 53 | 0.030 |
Why?
|
| Population Surveillance | 2 | 2004 | 2594 | 0.030 |
Why?
|
| Warts | 1 | 1996 | 66 | 0.030 |
Why?
|
| Deltaretrovirus Antibodies | 1 | 1996 | 9 | 0.030 |
Why?
|
| Immunoglobulin E | 2 | 2017 | 1480 | 0.030 |
Why?
|
| Parity | 1 | 1999 | 932 | 0.030 |
Why?
|
| Alanine Transaminase | 2 | 2002 | 608 | 0.030 |
Why?
|
| Hepatitis Viruses | 1 | 1995 | 15 | 0.030 |
Why?
|
| Regression Analysis | 3 | 1999 | 6321 | 0.030 |
Why?
|
| Virus Latency | 1 | 1998 | 360 | 0.030 |
Why?
|
| Sexual Partners | 1 | 2000 | 804 | 0.030 |
Why?
|
| Lymphoma | 1 | 2004 | 1897 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2009 | 18065 | 0.030 |
Why?
|
| Prospective Studies | 7 | 2017 | 54818 | 0.030 |
Why?
|
| Cell Line, Transformed | 2 | 1996 | 858 | 0.030 |
Why?
|
| Ulcer | 1 | 1996 | 202 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2004 | 1760 | 0.030 |
Why?
|
| CD4-CD8 Ratio | 1 | 1994 | 114 | 0.030 |
Why?
|
| Th1 Cells | 1 | 1999 | 1039 | 0.030 |
Why?
|
| Retina | 1 | 2005 | 2648 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2004 | 24299 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2005 | 4425 | 0.030 |
Why?
|
| Erythrocyte Count | 1 | 1994 | 157 | 0.030 |
Why?
|
| HTLV-I Antigens | 2 | 1991 | 7 | 0.030 |
Why?
|
| Reference Values | 2 | 2004 | 4910 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 1999 | 1375 | 0.030 |
Why?
|
| Child | 8 | 2005 | 80510 | 0.030 |
Why?
|
| Hematocrit | 1 | 1994 | 622 | 0.020 |
Why?
|
| Meat | 1 | 2015 | 588 | 0.020 |
Why?
|
| Forestry | 1 | 1992 | 9 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 1994 | 416 | 0.020 |
Why?
|
| HIV Seroprevalence | 1 | 1992 | 89 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2005 | 3816 | 0.020 |
Why?
|
| Molecular Sequence Data | 4 | 2004 | 17595 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 7599 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 2010 | 0.020 |
Why?
|
| Virus Activation | 1 | 2013 | 323 | 0.020 |
Why?
|
| Age of Onset | 1 | 1998 | 3341 | 0.020 |
Why?
|
| Toxoplasmosis | 1 | 1992 | 94 | 0.020 |
Why?
|
| Fisheries | 1 | 1992 | 48 | 0.020 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 1991 | 112 | 0.020 |
Why?
|
| Mice, SCID | 2 | 1996 | 2627 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 4772 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 1993 | 1060 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 1998 | 1352 | 0.020 |
Why?
|
| Precipitin Tests | 2 | 1989 | 812 | 0.020 |
Why?
|
| Leukopenia | 1 | 1991 | 213 | 0.020 |
Why?
|
| Morbidity | 1 | 1996 | 1752 | 0.020 |
Why?
|
| Serum Albumin | 1 | 1994 | 676 | 0.020 |
Why?
|
| Homosexuality | 2 | 1992 | 268 | 0.020 |
Why?
|
| DNA Replication | 1 | 1997 | 1432 | 0.020 |
Why?
|
| Agriculture | 1 | 1992 | 186 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 2005 | 2921 | 0.020 |
Why?
|
| Virus Integration | 2 | 2005 | 303 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2005 | 4046 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 1994 | 1865 | 0.020 |
Why?
|
| Organ Transplantation | 1 | 1999 | 1172 | 0.020 |
Why?
|
| Bisexuality | 2 | 1992 | 295 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 1996 | 1318 | 0.020 |
Why?
|
| B-Lymphocytes | 2 | 2017 | 4779 | 0.020 |
Why?
|
| Family | 2 | 1998 | 3208 | 0.020 |
Why?
|
| Capsid | 1 | 1991 | 435 | 0.020 |
Why?
|
| Cell Line | 2 | 2005 | 15541 | 0.020 |
Why?
|
| Homosexuality, Male | 1 | 1996 | 1342 | 0.020 |
Why?
|
| Dysgerminoma | 1 | 1988 | 66 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 1992 | 2011 | 0.020 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1991 | 297 | 0.020 |
Why?
|
| Tumor Virus Infections | 1 | 1991 | 438 | 0.020 |
Why?
|
| Research Design | 1 | 2004 | 6207 | 0.020 |
Why?
|
| Transplantation, Heterologous | 2 | 1996 | 2392 | 0.020 |
Why?
|
| Hemoglobins | 1 | 1994 | 1529 | 0.020 |
Why?
|
| Demography | 1 | 1992 | 1641 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2004 | 42481 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2021 | 12433 | 0.020 |
Why?
|
| Blotting, Western | 3 | 1991 | 5019 | 0.020 |
Why?
|
| Women's Health | 1 | 1996 | 2083 | 0.020 |
Why?
|
| Time Factors | 4 | 2004 | 40117 | 0.020 |
Why?
|
| Life Style | 2 | 2015 | 3929 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1992 | 1740 | 0.020 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1988 | 238 | 0.020 |
Why?
|
| Anemia | 1 | 1996 | 1511 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 14645 | 0.020 |
Why?
|
| Community Health Services | 2 | 2002 | 657 | 0.020 |
Why?
|
| Eosinophils | 1 | 1991 | 945 | 0.020 |
Why?
|
| Michigan | 1 | 1987 | 328 | 0.020 |
Why?
|
| Neopterin | 1 | 2005 | 57 | 0.020 |
Why?
|
| Terminal Repeat Sequences | 1 | 2005 | 70 | 0.020 |
Why?
|
| United States | 3 | 2021 | 72914 | 0.020 |
Why?
|
| Science | 1 | 2008 | 234 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 3804 | 0.020 |
Why?
|
| Greece | 2 | 1997 | 341 | 0.020 |
Why?
|
| Base Sequence | 3 | 2004 | 12402 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1996 | 2098 | 0.010 |
Why?
|
| Teratoma | 1 | 1988 | 402 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1997 | 4404 | 0.010 |
Why?
|
| DNA Fingerprinting | 1 | 2005 | 114 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 2005 | 330 | 0.010 |
Why?
|
| Receptors, IgE | 1 | 2006 | 374 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2005 | 765 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1997 | 4638 | 0.010 |
Why?
|
| Health Behavior | 1 | 2015 | 2649 | 0.010 |
Why?
|
| Prognosis | 1 | 2004 | 29915 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2015 | 3210 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1996 | 2821 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2004 | 472 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1998 | 14751 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2001 | 39226 | 0.010 |
Why?
|
| Clone Cells | 1 | 2005 | 1672 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1993 | 13402 | 0.010 |
Why?
|
| Cell Division | 2 | 1999 | 4473 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2008 | 2761 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1992 | 2499 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1991 | 2185 | 0.010 |
Why?
|
| Thymidine | 1 | 1999 | 294 | 0.010 |
Why?
|
| Virus Replication | 1 | 1987 | 2447 | 0.010 |
Why?
|
| Tritium | 1 | 1999 | 702 | 0.010 |
Why?
|
| HIV-1 | 2 | 1997 | 6944 | 0.010 |
Why?
|
| Mycobacterium bovis | 1 | 1999 | 148 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1988 | 3629 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 12969 | 0.010 |
Why?
|
| Analysis of Variance | 2 | 1998 | 6209 | 0.010 |
Why?
|
| Health Personnel | 1 | 1992 | 3389 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2015 | 13044 | 0.010 |
Why?
|
| Erythema | 1 | 1998 | 260 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1997 | 772 | 0.010 |
Why?
|
| Asthma | 1 | 1996 | 6269 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 1999 | 579 | 0.010 |
Why?
|
| BCG Vaccine | 1 | 1999 | 380 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 1998 | 81522 | 0.010 |
Why?
|
| Beta-Globulins | 1 | 1996 | 27 | 0.010 |
Why?
|
| Linear Models | 1 | 2006 | 5877 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1999 | 6489 | 0.010 |
Why?
|
| Histones | 1 | 2005 | 2592 | 0.010 |
Why?
|
| Hepatitis Antibodies | 1 | 1995 | 67 | 0.010 |
Why?
|
| Public Health | 1 | 2008 | 2678 | 0.010 |
Why?
|
| New York City | 1 | 1996 | 734 | 0.010 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 1995 | 96 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 1999 | 1145 | 0.010 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1995 | 294 | 0.010 |
Why?
|
| Animals | 4 | 1996 | 168721 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1999 | 1896 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1997 | 1731 | 0.010 |
Why?
|
| Genes, pX | 1 | 1991 | 7 | 0.010 |
Why?
|
| Retroviruses, Simian | 1 | 1991 | 12 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2004 | 3592 | 0.010 |
Why?
|
| Hepatitis B virus | 1 | 1995 | 530 | 0.010 |
Why?
|
| Radioimmunoprecipitation Assay | 1 | 1990 | 17 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1999 | 3159 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 11208 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1991 | 860 | 0.010 |
Why?
|
| Papio | 1 | 1991 | 671 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1989 | 12123 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2005 | 6607 | 0.010 |
Why?
|
| Eye Diseases | 1 | 1995 | 660 | 0.010 |
Why?
|
| Mice | 2 | 1996 | 81786 | 0.000 |
Why?
|
| Autoradiography | 1 | 1989 | 723 | 0.000 |
Why?
|
| Disease Progression | 1 | 2005 | 13615 | 0.000 |
Why?
|
| Blood Transfusion | 1 | 1995 | 1295 | 0.000 |
Why?
|
| Estrogen Replacement Therapy | 1 | 1994 | 1206 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1994 | 21062 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1989 | 1723 | 0.000 |
Why?
|
| Antibody Formation | 1 | 1991 | 1391 | 0.000 |
Why?
|
| Models, Statistical | 1 | 2001 | 5090 | 0.000 |
Why?
|
| Menopause | 1 | 1994 | 1661 | 0.000 |
Why?
|
| Mass Screening | 1 | 2001 | 5448 | 0.000 |
Why?
|
| Graft Survival | 1 | 1996 | 3897 | 0.000 |
Why?
|
| Fetal Blood | 1 | 1991 | 1369 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1999 | 18972 | 0.000 |
Why?
|
| Body Weight | 1 | 1994 | 4624 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1996 | 11036 | 0.000 |
Why?
|
| Infant | 1 | 2004 | 36377 | 0.000 |
Why?
|
| Databases, Factual | 1 | 1996 | 8062 | 0.000 |
Why?
|
| Trans-Activators | 1 | 1989 | 2850 | 0.000 |
Why?
|
| Health Status | 1 | 1992 | 4083 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 1995 | 5892 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1995 | 15803 | 0.000 |
Why?
|